Benefits of Lowering Cholesterol After Heart Attack

OCTOBER 01, 2002

In a recent study, people randomized to receive intensive cholesterol-lowering therapy during the 4 months after a heart attack or other coronary event had an approximately 50% lower risk of stroke than those not given this therapy, researchers reported in Circulation: Journal of the American Heart Association (September 3, 2002). During the 4-month follow-up, 36 of the 3086 subjects had a stroke; 12 had taken the cholesterol-lowering drug atorvastatin and 24 had not taken the drug. ?An estimated 1 million to 2 million people a year suffer from acute coronary syndromes in the United States alone. So if these results are confirmed in future studies, an absolute reduction of stroke of this order means that many strokes would be prevented,? said lead author David D. Waters, MD, professor at the University of California, San Francisco School of Medicine.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.